Cytek Biosciences, Inc. (CTKB) stock
CTKBNasdaqLaboratory Analytical InstrumentsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 8/308% below fair value
$5.84+0.32 (+5.80%)
Close on Nov 13, 2026Market cap $759.10MP/E –Yield –
Cytek Biosciences statistics
85 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.
Important dates
- Next earnings
- Feb 25, 2027 (estimated, during market hours)
- Last ex-dividend date
- No dividends
- Fundamentals through
- Sep 30, 2026
- Share price as of
- Nov 13, 2026
Valuation ratiosIndustry
- P/TBV Ratio
- 2.61
- 4.81
Enterprise valuationIndustry
- EV / Sales
- 3.33
- 2.60
Share statisticsIndustry
- Shares Change (YoY)
- 0.94%
- 3.32%
- Shares Change (QoQ)
- 0.61%
- 0.20%
- Float
- 116M
- 37M
- Shares Held by Insiders
- 10.6%
- 10.5%
- Shares Held by Institutions
- 62.7%
- 60.5%
Short sellingIndustry
- Short Interest
- 4M
- –
- Short Interest Change
- -6.89%
- -2.57%
- Short % of Float
- 3.53%
- 5.11%
- Short % of Shares Outstanding
- 3.16%
- 3.98%
- Days to Cover
- 3.56
- 3.94
Stock price statisticsIndustry
- 52-Week High
- $6.33
- –
- 52-Week Low
- $3.31
- –
- 20-Day Moving Average
- $5.76
- –
- 50-Day Moving Average
- $5.50
- –
- 200-Day Moving Average
- $4.68
- –
- Average True Range (14)
- $0.33
- –
- Price Change (1 Week)
- 0.17%
- 0.99%
- Price Change (1 Month)
- 7.95%
- -3.52%
- Price Change (3 Months)
- 23.2%
- -7.86%
- Price Change (6 Months)
- 71.5%
- -1.12%
- Price Change (YTD)
- 15.6%
- -2.92%
- Price Change (1 Year)
- 21.4%
- -1.37%
- Price Change (3 Years)
- 6.76%
- 3.24%
- Price Change (5 Years)
- -75.3%
- -50.4%
- Average Volume (10 Days)
- 1M
- –
- Average Volume (20 Days)
- 1M
- –
- Average Volume (90 Days)
- 1M
- –
- Relative Volume
- 1.14
- 0.76
- Relative Strength Index (14)
- 53.4
- 46.7
- Volatility (1 Year)
- 56.0%
- 64.2%
- Beta (5 Years)
- 1.09
- 1.04
MarginsIndustry
- EBITDA Margin
- -17.3%
- -2.52%
- FCF Margin
- -6.49%
- 0.65%
Returns on capitalIndustry
- Return on Equity (ROE)
- -23.2%
- -17.3%
- Return on Assets (ROA)
- -17.3%
- -12.3%
- Return on Invested Capital (ROIC)
- -12.8%
- -2.83%
- Return on Capital Employed (ROCE)
- -12.1%
- -8.13%
Financial positionIndustry
- Current Ratio
- 4.46
- 2.49
- Quick Ratio
- 1.48
- 1.53
- Interest Coverage
- -562.56
- -1.63
GrowthIndustry
- Revenue Growth (YoY)
- 5.50%
- 9.42%
- Revenue Growth (3Y CAGR)
- 7.10%
- 7.08%
- Revenue Growth (5Y CAGR)
- 209.5%
- 11.8%
EfficiencyIndustry
- Asset Turnover
- 0.44
- 0.59
- Inventory Turnover
- 1.81
- 2.20
- Revenue Per Employee
- $295.79K
- $331.99K
- Profits Per Employee
- -$115.67K
- -$46.47K
- Employee Count
- 702
- 193
- WACC
- 10.6%
- 9.91%
Income statement (TTM)Industry
Balance sheetIndustry
- Net Cash (Debt)
- $66.81M
- $3.95M
- Net Cash Per Share
- $0.51
- $0.26
- Equity (Book Value)
- $321.35M
- $63.80M
- Book Value Per Share
- $2.47
- $3.26
- Tangible Book Value
- $290.64M
- $11.61M
- Working Capital
- $293.98M
- $57.32M
Cash flow (TTM)Industry
- Capital Expenditures
- -$6.89M
- -$3.94M
- FCF Per Share
- -$0.10
- -$0.00
Dividends and yieldsIndustry
- Earnings Yield
- -10.7%
- -4.76%
- FCF Yield
- -1.78%
- 0.28%
- Buyback Yield
- -0.00%
- 0.80%
- Shareholder Yield
- -0.00%
- 1.12%
Taxes and interestIndustry
- Interest Expense
- $78.00K
- $5.40M
- Income Tax
- $41.24M
- $1.55M
Scores and fair valueIndustry
- Altman Z-Score
- 4.15
- 2.47
- Piotroski F-Score
- 3
- 5
- Beneish M-Score
- -3.29
- -2.64
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 13, 2026. The S&P 500 is measured by the SPY fund.
| Period | CTKB | S&P 500 | Difference | CTKB per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | +9.2% | -3.0% | +12.2 pts | ||
| 3 months | +19.4% | -2.8% | +22.2 pts | ||
| Year to date | +15.6% | +11.5% | +4.2 pts | ||
| 1 year | +27.8% | +13.5% | +14.3 pts | ||
| 3 years | +17.7% | +77.7% | −60.0 pts | +5.6% | +21.1% |
| 5 years | -75.3% | +72.6% | −147.9 pts | -24.4% | +11.5% |
Short interest
Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.
4M CTKB shares were sold short on Oct 30, 2026, down 6.9% from the previous report, or 3.53% of the shares available to trade. At recent volumes it would take 3.6 days to buy them back. Over the last 20 sessions, 37.5% of the volume reported to FINRA was short selling.
| Settlement date | Shares short | Change | Avg. daily volume | Days to cover |
|---|---|---|---|---|
| Oct 30, 2026 | 4,105,921 | -6.9% | 1,154,072 | 3.6 |
| Oct 15, 2026 | 4,409,745 | -15.5% | 1,644,691 | 2.7 |
| Sep 30, 2026 | 5,215,595 | -0.5% | 1,666,297 | 3.1 |
| Sep 15, 2026 | 5,242,079 | +6.3% | 913,672 | 5.7 |
| Aug 31, 2026 | 4,931,028 | -1.2% | 743,073 | 6.6 |
| Aug 14, 2026 | 4,989,610 | +1.9% | 982,404 | 5.1 |
| Jul 31, 2026 | 4,895,239 | -2.7% | 656,422 | 7.5 |
| Jul 15, 2026 | 5,029,578 | +43.4% | 921,162 | 5.5 |
| Jun 30, 2026 | 3,507,190 | -50.2% | 3,393,103 | 1.0 |
| Jun 15, 2026 | 7,042,866 | -3.6% | 1,273,593 | 5.5 |
| May 29, 2026 | 7,304,635 | +6.4% | 896,959 | 8.1 |
| May 15, 2026 | 6,864,944 | -11.3% | 1,151,002 | 6.0 |
Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.
See a number that looks wrong?